Genetic alterations predict lung cancer recurrence

Aisner, Joseph
April 2008
Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p34
The article provides information on a study on early lung cancer recurrence prediction. Findings show that methylation of the promoter region of four genes is linked to early recurrence in patients with non-small cell lung cancer (NSCLC) who are treated with curative surgery. It references a study published in a 2008 issue of the "New England Journal of Medicine."


Related Articles

  • Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Hung, J.-J.; Hsu, W.-H.; Hsieh, C.-C.; Huang, B.-S.; Huang, M.-H.; Liu, J.-S.; Wu, Y.-C. // Thorax;Mar2009, Vol. 64 Issue 3, p192 

    OBJECTIVE: Resection is the best treatment for patients with stage I non-small cell lung cancer (NSCLC). Patterns of disease recurrence after complete resection in stage I NSCLC have not been well demonstrated. The aim of this study was to evaluate the prognostic predictors of post-recurrence...

  • Treatment options for small cell lung cancer – do we have more choice? Puglisi, M.; Dolly, S.; Faria, A.; Myerson, J. S.; Popat, S.; O'Brien, M. E. R. // British Journal of Cancer;2/15/2010, Vol. 102 Issue 4, p629 

    Small cell lung cancer (SCLC) is a significant health problem worldwide because of its high propensity for relapse. This review discusses existing and future therapies for the treatment of SCLC.

  • Assay can predict survival.  // Oncology Nurse Advisor;Jan/Feb2012, Vol. 3 Issue 1, p10 

    No abstract available.

  • Detection of minimal residual disease in lung cancer. Chudacek, Josef; Bohanes, Tomas; Klein, Jiri; Benedikova, Andrea; Srovnal, Josef; Szkorupa, Marek; Skalicky, Pavel; Skarda, Jozef; Hajduch, Marian; Neoral, Cestmir // Biomedical Papers of the Medical Faculty of Palacky University i;Jun2014, Vol. 158 Issue 2, p189 

    Background. Even after successful radical treatment of lung cancer, patients in stages I and II of the TNM system very frequently suffer recurrence, which end lethally. Detection of subclinical residual disease after surgery is thus one of the most important emerging diagnostic methods. Minimal...

  • JUST IN. McBride, Deborah // ONS Connect;Oct2010, Vol. 25 Issue 10, p7 

    The article presents the findings on the efficiency of drugs and research procedures in the U.S. A study has revealed the efficiency of erlotinib in extending the life of women with advanced lung cancer. A study reveals that the use of biomarkers from breast tissue can predict the subsequent...

  • Prognosis of recurrent non-small cell lung cancer following complete resection. HIDEFUMI SASAKI; AYUMI SUZUKI; TSUTOMU TATEMATSU; MASAYUKI SHITARA; YU HIKOSAKA; KATSUHIRO OKUDA; SATORU MORIYAMA; MOTOKI YANO; YOSHITAKA FUJII // Oncology Letters;2014, Vol. 7 Issue 4, p1300 

    Prognosis following recurrence subsequent to complete resection of non-small-cell lung cancer (NSCLC) is considered a multifactorial process dependent on clinicopathological, biological and treatment characteristics. Geitinib was approved for lung cancer treatment in Japan in 2002. The aim of...

  • The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis. Wang, Jun; Wang, Baocheng; Chen, Xi; Bi, Jingwang // Carcinogenesis;Mar2011, Vol. 32 Issue 3, p411 

    Inactivation of the tumor suppressor gene RASSF1A through methylation of the CpG islands within its promoter region as a prognostic factor for survival in non-small cell lung carcinoma (NSCLC) remains controversial. A meta-analysis of published studies investigating the effects of RASSF1A...

  • DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma. Sato, Takashi; Arai, Eri; Kohno, Takashi; Tsuta, Koji; Watanabe, Shun-ichi; Soejima, Kenzo; Betsuyaku, Tomoko; Kanai, Yae // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    The aim of this study was to clarify the significance of DNA methylation alterations at precancerous stages of lung adenocarcinoma. Using single-CpG resolution Infinium array, genome-wide DNA methylation analysis was performed in 36 samples of normal lung tissue obtained from patients without...

  • Value of Follow-up Screening of Patients with Lung Cancer. Kirchner, Jeffrey T. // American Family Physician;1/15/1998, Vol. 57 Issue 2, p351 

    Presents a summary of the article `Utility screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma,' by E.A. Perez, et al, published in a 1997 edition of `Cancer' periodical.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics